Hereditary chorea - what else to consider when the Huntington's disease genetics test is negative?

N Malek1, E J Newman1

  • 1Department of Neurology, Institute of Neurosciences, Queen Elizabeth University Hospital, Glasgow, UK.

Insights

Huntington's disease (HD) phenocopies present with similar symptoms but lack a positive genetic test. Identifying these HD-like disorders through molecular testing is crucial for accurate diagnosis and patient understanding.

Area of Science:

  • Neurology
  • Genetics
  • Movement Disorders

Background:

  • Huntington's disease (HD) is characterized by chorea, cognitive decline, and behavioral changes, often with a positive family history.
  • While HD is a common cause, several hereditary conditions can mimic its presentation, known as HD phenocopies.
  • These phenocopies require consideration when genetic testing for HD is negative.

Purpose of the Study:

  • To review the phenotypes and diagnostic approaches for Huntington's disease-like (HDL) disorders.
  • To differentiate HDL conditions from classic HD when genetic testing is negative.
  • To highlight the importance of molecular genetic testing in diagnosing heterogeneous hereditary choreas.

Main Methods:

  • Systematic literature search of PubMed and Cochrane Database (1946-2016).
  • Inclusion of search terms: 'chorea', 'Huntington's disease', 'HDL', and 'phenocopies'.
  • Focus on progressive chorea with cognitive impairment in the absence of HD gene mutations.

Main Results:

  • HD phenocopies often present with additional movement disorders like myoclonus, dystonia, parkinsonism, and tics.
  • Molecular genetic testing is key to distinguishing various hereditary choreas from HD.
  • While many HDL disorders are not curable, precise diagnosis aids patient and family understanding.

Conclusions:

  • Accurate diagnosis of HD phenocopies is essential for appropriate patient management.
  • Advances in molecular genetics facilitate the differentiation of HD from its mimics.
  • Understanding the specific genetic basis of chorea improves patient counseling and care.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Genetic Lingo01:11

Genetic Lingo

Overview
117.1K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K